PRB1 and interstitial lung disease: As for serological results, a higher prevalence of antisynthetase antibodies was confirmed in the Ro52-positive group, also when considering the ILD subgroup, while no differences were found for ANA, anti-MDA5, anti-PM/Scl, and other MSA/MAA.